692 Shares in West Pharmaceutical Services, Inc. (NYSE:WST) Purchased by Moody National Bank Trust Division

Moody National Bank Trust Division bought a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 692 shares of the medical instruments supplier’s stock, valued at approximately $209,000.

Several other hedge funds and other institutional investors have also modified their holdings of WST. Alberta Investment Management Corp boosted its holdings in shares of West Pharmaceutical Services by 26.9% during the 4th quarter. Alberta Investment Management Corp now owns 22,338 shares of the medical instruments supplier’s stock worth $10,477,000 after buying an additional 4,738 shares during the period. American International Group Inc. boosted its holdings in West Pharmaceutical Services by 0.3% in the 4th quarter. American International Group Inc. now owns 23,223 shares of the medical instruments supplier’s stock valued at $10,892,000 after purchasing an additional 59 shares during the period. Fiduciary Trust Co. boosted its holdings in West Pharmaceutical Services by 8.0% in the 4th quarter. Fiduciary Trust Co. now owns 713 shares of the medical instruments supplier’s stock valued at $334,000 after purchasing an additional 53 shares during the period. Gotham Asset Management LLC boosted its holdings in West Pharmaceutical Services by 93.3% in the 4th quarter. Gotham Asset Management LLC now owns 1,260 shares of the medical instruments supplier’s stock valued at $591,000 after purchasing an additional 608 shares during the period. Finally, Siemens Fonds Invest GmbH boosted its holdings in West Pharmaceutical Services by 28.8% in the 4th quarter. Siemens Fonds Invest GmbH now owns 1,006 shares of the medical instruments supplier’s stock valued at $474,000 after purchasing an additional 225 shares during the period. Institutional investors own 91.98% of the company’s stock.

Insider Buying and Selling at West Pharmaceutical Services

In other news, insider Silji Abraham sold 5,374 shares of the company’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $343.93, for a total transaction of $1,848,279.82. Following the completion of the sale, the insider now owns 3,201 shares of the company’s stock, valued at approximately $1,100,919.93. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.60% of the company’s stock.

West Pharmaceutical Services Stock Performance

NYSE WST opened at $263.69 on Wednesday. The company has a quick ratio of 2.41, a current ratio of 3.13 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $19.53 billion, a P/E ratio of 29.27, a P/E/G ratio of 1.09 and a beta of 1.18. West Pharmaceutical Services, Inc. has a 12-month low of $261.31 and a 12-month high of $475.00. The firm has a 50-day moving average price of $311.87 and a two-hundred day moving average price of $329.79.

West Pharmaceutical Services (NYSE:WSTGet Rating) last posted its quarterly earnings data on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.19 by $0.28. The firm had revenue of $771.30 million during the quarter, compared to the consensus estimate of $754.25 million. West Pharmaceutical Services had a net margin of 23.41% and a return on equity of 29.08%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.46 EPS. Analysts anticipate that West Pharmaceutical Services, Inc. will post 9.09 earnings per share for the current year.

West Pharmaceutical Services Company Profile

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Featured Stories

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.